Data on the utilization of paraneoplastic syndrome autoantibody testing at an academic medical center

Paraneoplastic syndromes are rare conditions associated with characteristic autoantibodies produced by malignancy, although similar autoantibodies and clinical presentations may occur in the absence of any neoplasm. Testing for paraneoplastic syndromes often involves panels of autoantibody assays. W...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Matthew D. Krasowski, Anna Dolezal, Bryan W. Steussy, Michael P. Gailey, Benjamin W. Darbro
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Anti-N-methyl-D-aspartate receptor encephalitis Autoantibodies Paraneoplastic syndromes Utilization review Voltage-gated calcium channels Voltage-gated potassium channels Computer applications to medicine. Medical informatics R858-859.7 Science (General) Q1-390
Acceso en línea:	https://doaj.org/article/5e6e9eba705848c1821f3d4e0a3e81f9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5e6e9eba705848c1821f3d4e0a3e81f9
record_format	dspace
spelling	oai:doaj.org-article:5e6e9eba705848c1821f3d4e0a3e81f92021-11-24T04:31:27ZData on the utilization of paraneoplastic syndrome autoantibody testing at an academic medical center2352-340910.1016/j.dib.2021.107578https://doaj.org/article/5e6e9eba705848c1821f3d4e0a3e81f92021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2352340921008532https://doaj.org/toc/2352-3409Paraneoplastic syndromes are rare conditions associated with characteristic autoantibodies produced by malignancy, although similar autoantibodies and clinical presentations may occur in the absence of any neoplasm. Testing for paraneoplastic syndromes often involves panels of autoantibody assays. While autoantibody testing may reveal or confirm actionable clinical diagnoses, inappropriate utilization of testing may be low yield and further lead to false positives that may confuse the clinical picture. There is thus opportunity to improve patient care by analyzing patterns of paraneoplastic autoantibody test utilization. The data in this article provides results from detailed retrospective review of patients tested by 7 autoantibody tests or test panels offered by two large reference laboratories in the United States. The data include 1,446 tests performed on 1,338 unique patients at an academic medical center. For all results, detailed chart review revealed main category of presenting symptoms, patient location at time of testing (either inpatient or outpatient), sex, age, whether cancer was present at the time of testing or later detected, and the specific results of the testing. The data are summarized by category of testing and specific autoantibodies.Matthew D. KrasowskiAnna DolezalBryan W. SteussyMichael P. GaileyBenjamin W. DarbroElsevierarticleAnti-N-methyl-D-aspartate receptor encephalitisAutoantibodiesParaneoplastic syndromesUtilization reviewVoltage-gated calcium channelsVoltage-gated potassium channelsComputer applications to medicine. Medical informaticsR858-859.7Science (General)Q1-390ENData in Brief, Vol 39, Iss , Pp 107578- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Anti-N-methyl-D-aspartate receptor encephalitis Autoantibodies Paraneoplastic syndromes Utilization review Voltage-gated calcium channels Voltage-gated potassium channels Computer applications to medicine. Medical informatics R858-859.7 Science (General) Q1-390
spellingShingle	Anti-N-methyl-D-aspartate receptor encephalitis Autoantibodies Paraneoplastic syndromes Utilization review Voltage-gated calcium channels Voltage-gated potassium channels Computer applications to medicine. Medical informatics R858-859.7 Science (General) Q1-390 Matthew D. Krasowski Anna Dolezal Bryan W. Steussy Michael P. Gailey Benjamin W. Darbro Data on the utilization of paraneoplastic syndrome autoantibody testing at an academic medical center
description	Paraneoplastic syndromes are rare conditions associated with characteristic autoantibodies produced by malignancy, although similar autoantibodies and clinical presentations may occur in the absence of any neoplasm. Testing for paraneoplastic syndromes often involves panels of autoantibody assays. While autoantibody testing may reveal or confirm actionable clinical diagnoses, inappropriate utilization of testing may be low yield and further lead to false positives that may confuse the clinical picture. There is thus opportunity to improve patient care by analyzing patterns of paraneoplastic autoantibody test utilization. The data in this article provides results from detailed retrospective review of patients tested by 7 autoantibody tests or test panels offered by two large reference laboratories in the United States. The data include 1,446 tests performed on 1,338 unique patients at an academic medical center. For all results, detailed chart review revealed main category of presenting symptoms, patient location at time of testing (either inpatient or outpatient), sex, age, whether cancer was present at the time of testing or later detected, and the specific results of the testing. The data are summarized by category of testing and specific autoantibodies.
format	article
author	Matthew D. Krasowski Anna Dolezal Bryan W. Steussy Michael P. Gailey Benjamin W. Darbro
author_facet	Matthew D. Krasowski Anna Dolezal Bryan W. Steussy Michael P. Gailey Benjamin W. Darbro
author_sort	Matthew D. Krasowski
title	Data on the utilization of paraneoplastic syndrome autoantibody testing at an academic medical center
title_short	Data on the utilization of paraneoplastic syndrome autoantibody testing at an academic medical center
title_full	Data on the utilization of paraneoplastic syndrome autoantibody testing at an academic medical center
title_fullStr	Data on the utilization of paraneoplastic syndrome autoantibody testing at an academic medical center
title_full_unstemmed	Data on the utilization of paraneoplastic syndrome autoantibody testing at an academic medical center
title_sort	data on the utilization of paraneoplastic syndrome autoantibody testing at an academic medical center
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/5e6e9eba705848c1821f3d4e0a3e81f9
work_keys_str_mv	AT matthewdkrasowski dataontheutilizationofparaneoplasticsyndromeautoantibodytestingatanacademicmedicalcenter AT annadolezal dataontheutilizationofparaneoplasticsyndromeautoantibodytestingatanacademicmedicalcenter AT bryanwsteussy dataontheutilizationofparaneoplasticsyndromeautoantibodytestingatanacademicmedicalcenter AT michaelpgailey dataontheutilizationofparaneoplasticsyndromeautoantibodytestingatanacademicmedicalcenter AT benjaminwdarbro dataontheutilizationofparaneoplasticsyndromeautoantibodytestingatanacademicmedicalcenter
_version_	1718415977250553856

Data on the utilization of paraneoplastic syndrome autoantibody testing at an academic medical center

Ejemplares similares